Life Science Leader Blogs

  1. How Can The Pharma Industry Help The Homeless?

    Readers provide feedback and suggestions around how the biopharmaceutical industry could help the homeless during the annual J.P. Morgan Healthcare Conference in San Francisco.

  2. The R&D Leadership Summit 2018 — One Hot Ticket

    The Conference Forum’s 2018 R&D Leadership Summit employs the Chatham House Rule, which limits what information can be revealed from the event's proceedings. As one of the only members of the media in the room, Chief Editor Rob Wright shares what he can from this year's event, which had the theme “Growth: Where Will It Come From?”

  3. Your Bio Company’s Story: The Mechanics Of Clarity

    Here, I aim to offer some additional ideas for how companies can best describe themselves and their products — and how PR agents, journalists, and others might describe them — by achieving the opposite of hype: clarity.

  4. J&J’s Addition Of JLABS in New York City Creates Buzz At BIO CEO 2018

    Rob Wright interviews Kate Merton, head of Johnson & Johnson Innovation’s newly created JLABS in New York City.

  5. Jeremy Levin On BIO’s Efforts Toward Tackling The Opioid Crisis

    Rob Wright interviews Jeremy Levin, chairman and CEO of Ovid Therapeutics, about the BIO opioid crisis working group he is chairing.

  6. What Oppenheimer Is Doing To Support Healthcare Investors

    Rob Wright video interviews Michael Margolis, R.Ph, head of life sciences and co-head of healthcare investment banking at Oppenheimer & Co. Inc. during the 2018 BIO CEO & Investor Conference in New York.

  7. Why CytoSorbents Has The BIO CEO Investor Community Buzzing

    Rob Wright video interviews CytoSorbents’ CEO, Dr. Philip Chan, about CytoSorb, the company’s lead product described as a “Brita filter for your blood,” during the 2018 BIO CEO & Investor Conference in New York.

  8. Atreca Is Doing More Than Just Creating A Buzz At BIO CEO 2018

    Rob Wright video interviews Atreca CEO, Tito Serafini, during the 2018 BIO CEO & Investor Conference in New York about the company’s search for antigens that are driving successful immune responses in cancer patients.

  9. Gender Diversity In Leadership - How Does Biopharma Compare?

    How the 10 largest publicly traded biopharmaceutical companies compare to 10 of the largest publicly traded nonbiopharmaceutical companies in the area of gender diversity among executive leadership.

  10. Is It Time For Branded Biopharmaceuticals To Get Into The Business Of Generics?

    With President Trump’s recently announced focus on reducing the price of prescription drugs, perhaps it is time branded biopharmaceutical companies consider competing in other areas beyond just biosimilars (i.e., generic biologics).